cornellbreastcenter.com
Phase 1b/2 Study to Evaluate the Efficacy and Safety of Eribulin Mesylate in Combination with Pembrolizumab in Subjects With Metastatic Triple Negative Breast Cancer
Dr. Linda Vahdat is seeking volunteers for a new research study in triple negative breast cancer. This clinical trial is for women with metastatic triple-negative breast cancer (mTNBC). This means …